Infusion Therapy

InTandem Capital Partners, LLC (“InTandem Capital”), a healthcare services focused private equity firm, announced today that its affiliated funds, InTandem Capital Partners Fund II, LP and InTandem Capital Opportunities Fund, LP, have completed a majority recapitalization and combination of MPP Infusion Centers and ID Consultants, both leading providers of accessible and affordable ambulatory infusion services.

Ridgemont Equity Partners, a buyout and growth equity investor, today announced the acquisition of American Outcomes Management (“AOM” or the “Company”), a leading specialty infusion provider focused on intravenous immunoglobulin (“IVIG”) infusion therapy. AOM provides home-based IVIG therapy to patients with over 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The

Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2021. The Company also announced that it acquired Wasatch Infusion LLC (“Wasatch”), an infusion center operator based